Free Trial

Kimberly-Clark (KMB) Stock Forecast & Price Target

$142.01
+1.23 (+0.87%)
(As of 10/8/2024 ET)

Kimberly-Clark - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
8
Buy
6

Based on 16 Wall Street analysts who have issued ratings for Kimberly-Clark in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 2 have given a sell rating, 8 have given a hold rating, and 6 have given a buy rating for KMB.

Consensus Price Target

$146.00
2.81% Upside
According to the 16 analysts' twelve-month price targets for Kimberly-Clark, the average price target is $146.00. The highest price target for KMB is $174.00, while the lowest price target for KMB is $118.00. The average price target represents a forecasted upside of 2.81% from the current price of $142.01.
Get the Latest News and Ratings for KMB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kimberly-Clark and its competitors.

Sign Up

KMB Analyst Ratings Over Time

TypeCurrent Forecast
10/9/23 to 10/8/24
1 Month Ago
9/9/23 to 9/8/24
3 Months Ago
7/11/23 to 7/10/24
1 Year Ago
10/9/22 to 10/9/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
1 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$146.00$145.67$141.79$135.15
Forecasted Upside2.81% Upside-0.85% Downside0.74% Upside13.99% Upside
Consensus Rating
Hold
Hold
Hold
Reduce

KMB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KMB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Kimberly-Clark Stock vs. The Competition

TypeKimberly-ClarkConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.25
2.44
2.50
Consensus RatingHoldHoldHold
Predicted Upside3.23% Upside129.45% Upside7.88% Upside
News Sentiment Rating
Positive News

See Recent KMB News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/8/2024Deutsche Bank Aktiengesellschaft
2 of 5 stars
 Boost TargetHold ➝ Hold$146.00 ➝ $147.00+4.09%
7/26/2024Argus
3 of 5 stars
T. Conrad
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/24/2024Royal Bank of Canada
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$165.00 ➝ $165.00+18.48%
7/24/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$138.00 ➝ $134.00-3.15%
7/23/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$161.00+11.70%
7/22/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$123.00 ➝ $135.00-5.84%
7/19/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$136.00 ➝ $135.00-6.22%
7/11/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$167.00 ➝ $174.00+23.62%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$146.00+4.68%
6/13/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Buy$115.00 ➝ $160.00+18.35%
4/24/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$111.00 ➝ $125.00-9.16%
4/24/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$146.00 ➝ $150.00+9.19%
4/24/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$135.00 ➝ $138.00+0.61%
4/24/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$135.00 ➝ $152.00+11.50%
3/28/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$133.00 ➝ $150.00+17.86%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform$125.00 ➝ $118.00-1.17%
4/26/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$132.00 ➝ $144.00-0.46%
4/17/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$132.00 ➝ $140.00+1.42%
1/4/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$137.00 ➝ $139.00+1.38%
10/12/2022Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$135.00+21.22%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:17 PM ET.


Should I Buy Kimberly-Clark Stock? KMB Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these Kimberly-Clark pros and cons to contact@marketbeat.com.

Kimberly-Clark
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Kimberly-Clark Co.:

  • Kimberly-Clark Co. has a stable market capitalization of $47.73 billion, indicating a strong position in the market.
  • The company's current price-to-earnings ratio of 26.20 suggests potential undervaluation compared to industry peers, making it an attractive investment opportunity.
  • Recent insider activity, such as Jeffrey P. Melucci selling shares at an average price of $141.42, could indicate confidence in the company's future performance.
  • Institutional investors and hedge funds own 76.29% of Kimberly-Clark Co.'s stock, signaling institutional confidence in the company's growth prospects.
  • Kimberly-Clark Co. has a diverse product portfolio across personal care, consumer tissue, and professional segments, providing stability and potential for growth.

Kimberly-Clark
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Kimberly-Clark Co. for these reasons:

  • Analysts have given mixed ratings on the stock, with two sell ratings and a consensus rating of "Hold," indicating uncertainty about the company's future performance.
  • The company's debt-to-equity ratio of 5.59 is relatively high, which may pose risks in times of economic downturns or rising interest rates.
  • Kimberly-Clark Co.'s beta of 0.39 suggests lower volatility compared to the market, potentially limiting short-term trading opportunities for investors seeking higher returns.
  • The PEG ratio of 3.00 indicates that the stock may be overvalued relative to its expected earnings growth, raising concerns about its valuation.
  • While the company has a history of dividend payments, investors should consider the sustainability of dividends given the company's financial metrics and market conditions.

KMB Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Kimberly-Clark is $146.00, with a high forecast of $174.00 and a low forecast of $118.00.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kimberly-Clark in the last year. There are currently 2 sell ratings, 8 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KMB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KMB, but not buy additional shares or sell existing shares.

According to analysts, Kimberly-Clark's stock has a predicted upside of 2.81% based on their 12-month stock forecasts.

Over the previous 90 days, Kimberly-Clark's stock had 1 upgrade by analysts.

Kimberly-Clark has been rated by research analysts at Argus, Barclays, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, TD Cowen, and Wells Fargo & Company in the past 90 days.

Analysts like Kimberly-Clark less than other "consumer staples" companies. The consensus rating score for Kimberly-Clark is 2.25 while the average consensus rating score for "consumer staples" companies is 2.45. Learn more on how KMB compares to other companies.


This page (NYSE:KMB) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners